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Introduction
The importance of MEFV gene protein, Pyrin/Marenostrin
(P/M) in the inflammatory pathway is well established.
P/M is expressed in neutrophils, eosinophils, monocytes,
dendritic cells and synovial fibroblasts. There are many
MEFV transcripts which are generated by alternative
splicing events including deleted exons 2,3,4,5,7 and 8 in
several combinations or individually. Some of these tran-
scripts (2a, 2d, 8ext, 2d/8ext and 2d/9ext) were shown to
be expressed as protein isoforms in leukocytes. A previous
study carried out by our group has shown that exon 2
deleted form (d2) in leukocyte samples of FMF patients is
expressed more than 400 fold compared to healthy control
samples (p=0.026).
Objectives
Based on the hypothesis that different localizations and
functions for full length and MEFV alternatively spliced
transcripts, this study aimed to determine the localization
differences between full-length P/M and P/M-d2 protein
isoforms in neutrophil-like cells in vitro.
Methods
Two GFP-tagged plasmids which are are pCMV6-AC-GFP
+ MEFV-fl (MEFV-fl-GFP) and pCMV6-AC-GFP +
MEFV-d2 (MEFV-d2-GFP) were transfected to HL-60
(Human promyelocytic leukemia cells) cell lines and
examined via confocal microscopy. Subsequently, six-day
incubation with 1.75% DMSO was performed to differenti-
ate HL-60 cells to neutrophil-like cells. These cells were
also transfected with same plasmids and proteins were
observed through confocal microscopy technique.
Results
Transfection studies showed that MEFV-fl-GFP was
cytoplasmic and MEFV-d2-GFP was nuclear in HL-60
cell line. On the other hand, both MEFV-fl-GFP
and MEFV-d2-GFP were localized in cytoplasm of
neutrophil-like cells.
Conclusion
In previous studies, cellular localization of P/M-fl and
P/M-d2 was investigated in several cell lines through
using transfection methods or P/M antibody. Transfec-
tion studies showed that full-length P/M was generally
cytoplasmic and 2Δ isoform was the only isoform which
can enter nucleus but may also localize in cytoplasm.
However localization studies using P/M antibodies,
which cannot currently distinguish between different
isoforms, showed that although native P/M consists of
predominantly full-length type, protein was also observed
in the nucleus of neutrophils. Our localization results of
P/M-fl and P/M-d2 in HL-60 cells were compatible with
literature, they were observed in the cytoplasm and
nucleus, respectively. On the other hand, both P/M-d2
and P/M-fl isoforms were found to be localized only
in cytoplasm not in nucleus in the neutrophil-like
cells. These findings had led us to suggest that post-
transcriptional modifications for P/M-d2 that may occur
during cell differentiation or possibly through inflamma-
tion such that its natural localization in the nucleus may
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